Basic Information
| LncRNA/CircRNA Name | CRYM-AS1 |
| Synonyms | NCRNA00169 |
| Region | GRCh38_16:21300849-21339037 |
| Ensemble | ENSG00000189149 |
| Refseq | NR_026675 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | thyroid cancer |
| ICD-0-3 | C73.9 |
| Methods | qPCR, Western blot, etc. |
| Sample | cell lines (BHT101, BCPAP) |
| Expression Pattern | down-regulated |
| Function Description | whereas thyroid cancer patients with higher PAX8-AS1 or lower CRYM-AS1 expression levels had shorter RFS time |
| Pubmed ID | 29923329 |
| Year | 2018 |
| Title | Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses. |
External Links
| Links for CRYM-AS1 | GenBank HGNC NONCODE |
| Links for thyroid cancer | OMIM COSMIC |